Docandu is an innovative digital health platform designed both for patients & doctors, making digital healthcare accessible from anywhere. Docandu aims to be a key tech health service provider, starting from Greece, improving the existing national and private health care services. The global digital health market is estimated to be worth $536 Billion by 2025. To date, they have developed two separate apps for doctors and patients. They have also received an angel investment of 100,000 Euros and sponsorship of $25,000 from Microsoft. The company has initiated early-stage relationships with a couple of Greek public and private health entities. With the proceeds, they will execute their go-to-market strategy and make global health ID a reality, by expanding its affiliate network of doctors, health providers and public health systems.
days to go:
Expired
investment:
£70,900
ePOS Hybrid has developed a fully connected ePOS platform dedicated to the hospitality food industry. The company is on a mission to empower hospitality businesses to harness technology to improve the business operations, customer experience and profitability. Till now, they have secured an enterprise customer with locations throughout the UK and, in just 8 months, scaled from 0 to 200 customers, processing more than 400k orders. With the proceeds, the company plans to accelerate growth by increasing its market awareness and boosting sales.
days to go:
Expired
investment:
£363,830
Active Needle Technology offers an award-winning "needle actuating device" which has high value medical and consumer applications. The company's patent-pending proprietary ultrasonic technology enhances visibility for medical needles in applications such as biopsy, in regional and joint anaesthesia and others. The company aims to commercialise its technology into a $4+ billion special purpose needle market. After identifying obvious commercial advantages in the tattoo market, Active Needle plans to use its ultrasonic needle technology to develop a low-pain tattooing system. Moreover, the company has won an Innovate UK grant to develop and test the tattoo device. With the proceeds, the company will complete CE marking for its initial biopsy device, for development of anaesthesia and tattooing products.
days to go:
Expired
investment:
£194,100
Luas Diagnostics (LD) aims to develop and market easy-to-use, rapid and accurate diagnostics tests with the aim of deploying these tests in remote settings away from centralised testing laboratories. The company has signed an exclusive distribution agreement with Chembio Diagnostics Systems (CDS) in the USA to market its Covid-19 antibody and antigen tests in the UK and Ireland. It has also signed a Memorandum of Understanding (MoU) with the University of Birmingham to develop saliva-based, rapid Covid-19 tests. LD is also working on coming up with a therapeutic drug monitoring system based on the same technology used worldwide to test people with diabetes for glucose levels in the blood. The company is developing the system so that it can be used at home, in pharmacies or GP surgery. The first product will test for Theophylline which is used to treat Chronic Obstructive Pulmonary Disease (COPD). LD will use the investment to grow its business across different verticals.
days to go:
Expired
investment:
£326,190
Rightangled is a healthcare technology company backed by NHS England & regulated by the Care Quality Commission (CQC). It began its journey as a platform that would enable the use of genetic information within the medical practice, in an accurate, streamlined, and affordable way. It gradually established itself as a healthcare provider for screening and diagnostic services. Its Heart DNA Test project, launched in 2017, is helping patients minimize their cardiac risks and enabling doctors to have a complete risk profile for their patients. The project was appreciated and received funding from NHS England. Its next project, Fitness DNA Test, tapped into the fitness and wellbeing markets. Recently, in the wake of the COVID-19 threat, the company has developed a home-based throat swab test to detect the viral infection, by testing viral load presented in its nucleic acid material within (RNA). For its efforts, Rightangled has been featured on CNN, Sky News, LBC radio, Sky News radio, and Newsweek. With the investment, the company aims to release a mobile application by the end of 2020, and develop an AI system to give instant tailored health, diet, and fitness advice to its users based on the data gathered from patient-doctor interactions and patient responses.
days to go:
Expired
investment:
£522,689
Ascot Brewing are passionate brewing award-winning real ales and hop-forward craft beers. They are on a mission to deliver value for its shareholders and customers while providing opportunities for its employees. They have opened a 2,500sq ft,20 tap - taproom and launched its hop-forward craft beer brand. Till now there are 785 investors backing Ascot Brewing Company and they have recently moved to new 8,500 sq. Ft building & installed new brewing kit. The company have successfully launched our hop-forward craft beer brand (Disruption is Brewing®). Ascot Brewing is seeking investment to expand the sales team, build out one of the best taprooms in the UK, growing export trade, add a small canning line, and address export inquiries.
days to go:
Expired
investment:
£150,000
Doodle Drinks (DD) aims to make all-natural soft drinks that kids can enjoy. The company cites research data arguing that children aged 18 months to 18 years are drinking 26% fewer sugary drinks and consumption for 10-year olds has fallen 35%. It wants to capture this sentiment and deliver a soft drink that's a healthy choice for both parents and their kids. DD has secured distribution with the noted distributor, Bravura Foods. It has also signed a partnership with the largest independent bottler of beverages in Europe and North America, Refresco, who have over 60 manufacturing sites globally to fulfil its objective. DD will use the investment to grow its business, execute its marketing strategy and increase its product range.
days to go:
Expired
investment:
£877,830
TheVeganKind is a plant-based supermarket subscription box service that sells different vegan and plant-based products. The company has generated a revenue of £2.5m during Nov 2018-Nov 2019. TheVeganKind had shipped more than 130,000 orders alone in 2019. There are more than 4,500 different vegan and plant-based products in stock. It has been recently voted the UK's Top Online Retailer for Vegan Shopping. TheVeganKind has more than 500,000 social followers across Facebook, Twitter, and Instagram. With the proceeds, the company will allocate 60% of the funds towards marketing and branding; 20% will go towards warehouse expansion, and in increasing its inventory; 20% will go towards operating expenditure and team expansion.
days to go:
Expired
investment:
£669,188
Alyve provides personalised subscription nutrition powered by Artificial Intelligence (AI). It argues that 8.2 million UK vitamin users are looking for personalised nutrition in one capsule. Alyve asserts that its product can fulfil this demand. Users complete a 3-minute questionnaire where their responses are recorded by Alyve's intelligent algorithms. These then, based on the responses, help the user select one of Alyve's nutritional pills best matched to their goals and needs. Alyve then delivers the pills to the user's doorstep every 30 days. The company has recorded 4000+ questionnaires and completed 800+ orders in 25 countries since Q4 of 2020. It aims to become a contender in the $21 billion supplement market. The company will use the investment received to increase marketing efforts, transform Alyve into a household brand, introduce new product lines, increase staff, improve technology, and transform both digital and physical User Experiences (UX).
days to go:
Expired
investment:
£227,782
Nelson's Distillery & School (NDAS) makes and sells craft gin from its 290-litre state-of-the-art establishment. It also educates interested folks from its 28 seat Gin school in the art of making quality craft gin. Former Chef and founder, Neil Harrison, set out to create the best craft Gin and to educate others in the process. The company has produced and sold over 100,000 bottles since its founding in 2019. It aspires to become a contender in the global gin market valued at $15 billion. NDAS asserts that it is one of a few craft gin companies to win the coveted 3-star Great British Taste award, plus 6 other awards over 2 years. The company has also signed four contracts with the Hilton & Clayton hotels, three in the UK and one in Asia. NDAS will use the investment to expand its business and establish Nelson’s Gin school in all major cities.
days to go:
Expired
investment:
£317,868
